Vanguard Capital Management’s Picard Medical PMI Stock Holding History

Vanguard Capital Management’s Portfolio PMI Stock Details PMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$413K	Buy	+50,368	New	+$1.07M	﹤0.01%	3741

Other funds holding PMI

IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

PCA

Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return

WMP

Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return

Vanguard Capital Management's PMI Position: Q2 2026 in Review

Vanguard Capital Management opened a new position in Picard Medical (PMI) in Q2 2026: 50,368 shares worth $413K. The stake represents ﹤0.01% of the portfolio and ranks #3741 among its holdings.

34 funds tracked by Wall St. Rank hold PMI as of Q2 2026.

Vanguard Capital Management held 50,368 shares of Picard Medical worth $413K as of Q2 2026.
Picard Medical was a new Vanguard Capital Management position in Q2 2026.
Picard Medical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3741 holding.
34 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.